Donald L. Hagan LLC Has $1.54 Million Position in The Clorox Company (NYSE:CLX)

Donald L. Hagan LLC increased its stake in shares of The Clorox Company (NYSE:CLX) by 2.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,477 shares of the company’s stock after purchasing an additional 287 shares during the quarter. Clorox makes up about 0.8% of Donald L. Hagan LLC’s portfolio, making the stock its 26th largest holding. Donald L. Hagan LLC’s holdings in Clorox were worth $1,543,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in CLX. Redwood Park Advisors LLC bought a new stake in Clorox during the 4th quarter worth approximately $26,000. Millstone Evans Group LLC bought a new position in Clorox during the fourth quarter worth $31,000. Wood Tarver Financial Group LLC bought a new position in Clorox during the fourth quarter worth $31,000. Asset Planning Inc bought a new position in Clorox during the fourth quarter worth $32,000. Finally, GKV Capital Management Co. Inc. bought a new position in Clorox during the fourth quarter worth $32,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Citigroup lowered their price objective on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a report on Monday, April 14th. Wells Fargo & Company reduced their price target on shares of Clorox from $145.00 to $142.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 6th. Evercore ISI set a $140.00 target price on shares of Clorox and gave the stock an “underperform” rating in a research report on Tuesday, May 6th. Morgan Stanley cut their target price on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 6th. Finally, JPMorgan Chase & Co. cut their target price on shares of Clorox from $151.00 to $144.00 and set a “neutral” rating for the company in a research report on Tuesday, May 6th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $151.23.

Clorox Price Performance

CLX stock opened at $127.25 on Friday. The firm has a 50 day moving average of $135.18 and a 200-day moving average of $148.78. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $125.77 and a 12 month high of $171.37. The firm has a market capitalization of $15.68 billion, a P/E ratio of 34.77, a price-to-earnings-growth ratio of 2.62 and a beta of 0.54.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. Clorox’s revenue was down 8.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.71 earnings per share. As a group, sell-side analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Insider Activity at Clorox

In related news, Director Pierre R. Breber bought 4,000 shares of the stock in a transaction that occurred on Wednesday, May 7th. The shares were acquired at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the purchase, the director now directly owns 4,000 shares of the company’s stock, valued at $546,280. This trade represents a ? increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.57% of the stock is currently owned by insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.